Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C35 - Treatment of Pediatric Multiple Sclerosis in the Current Era

Sunday 04/14/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | Mile High 4CD
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jennifer Graves, MD, PhD
Child Neurology and Developmental Neurology, Multiple Sclerosis
Participants should be able to understand the approach to the diagnosis of pediatric MS and unique features of the disease in children; summarize current literature regarding treatments for acute relapses and for disease modulation; and address symptomatic management, cognitive symptoms, mental wellness and physical activity, and strategies for rehabilitation.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials

Event Timeline
07:00 AM - 07:50 AM MDT Speaker Unique Features of Pediatric MS and Updates in Treatment Approaches
Jennifer Graves, MD, PhD
07:50 AM - 08:40 AM MDT Speaker Neurocognitive Aspects of Pediatric MS and Their Management
Lauren B. Krupp, MD, FAAN
08:40 AM - 09:00 AM MDT Q&A Faculty Discussion, Questions, & Answers
Jennifer Graves, MD, PhD, Lauren B. Krupp, MD, FAAN
Faculty Disclosures
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Lauren B. Krupp, MD, FAAN Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.